Overview: Glycolic Acid TestIntroduction: The Glycolic Acid Test measures glycolic acid to diagnose primary hyperoxaluria, causing kidney stones or kidney failure, helping guide treatment to prevent complications. Affecting 1 in 100,000 people, primary hyperoxaluria poses diagnostic challenges due to progressive kidney damage. Following 2023 American Society of Nephrology (ASN) guidelines, it uses GC-MS for high accuracy, supporting biochemistry screening. This test is vital for diagnosis, intervention planning, and improving outcomes in nephrology.
Other Names: Glycolic Acid Level Test, Hyperoxaluria Assay.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic reliability.
Historical Milestone: Oxalate metabolite testing began in the 1970s with research by Williams, who identified glycolic acid in hyperoxaluria. GC-MS advancements in the 1990s by Agilent improved detection, surpassing earlier enzymatic methods.
Purpose: Measures glycolic acid levels to diagnose primary hyperoxaluria, guides vitamin B6 therapy or dialysis, and evaluates patients with kidney stones, aiming to prevent failure.
Test Parameters: Glycolic acid levels
Pretest Condition: No special preparation required. Collect urine. Report history of kidney issues.
Specimen: Urine (sterile container, 5-20 mL); 10 mL urine in sterile container. Transport in a biohazard container.
Sample Stability at Room Temperature: 4 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: 1 month
Medical History: Document kidney stones or kidney failure. Include current medications or dietary habits.
Consent: Written consent required, detailing the test's purpose, disease risks (e.g., renal failure), and sample collection risks.
Procedural Considerations: Uses GC-MS to measure glycolic acid, requiring labs with gas chromatographs. Results available in 2-3 days. Performed in labs with strict handling.
Factors Affecting Result Accuracy: Sample degradation or contamination can affect results. Medications may not affect results but require correlation.
Clinical Significance: Elevated glycolic acid confirms hyperoxaluria, guiding therapy. Early treatment might prevent kidney damage, while untreated cases lead to failure. Normal levels may require imaging.
Specialist Consultation: Consult a nephrologist for interpretation.
Additional Supporting Tests: Urine oxalate test, liver biopsy, or genetic panel to confirm diagnosis.
Test Limitations: Specific to glycolic acid; correlation with symptoms needed. False negatives possible with low levels.
References: ASN Guidelines, 2023; Kidney International, Williams HE, 2022.
